Contribution of Inosinic Acid to the Activation of Diphosphothiamine in Liver-Pyruvate Oxidase System1

Total Page:16

File Type:pdf, Size:1020Kb

Contribution of Inosinic Acid to the Activation of Diphosphothiamine in Liver-Pyruvate Oxidase System1 THEJOURNAL OFVITAMINOLOGY 7, 271-275 (1961) CONTRIBUTION OF INOSINIC ACID TO THE ACTIVATION OF DIPHOSPHOTHIAMINE IN LIVER-PYRUVATE OXIDASE SYSTEM1 AKIOMAEKAWA, JUNZO HAYASHI, TAKEICHI OSHIMA, TAKAO SUZUKI ANDYOSHIKAZU SAHASHI Laboratoryof Biochemistryand Nutrition,Department of Agricultural Chemistry,Tokyo Agricultural University, Setagaya, Chitose, Tokyo (ReceivedSeptember 8, 1961) It is well known that the enzymatic formation of diphosphothiamine (DPT) takes place with adenosine triphosphate (ATP) as a phosphorylating agent. K. Lohmann and P. Schuster (1) first found that the extracts of the brain and other tissues could serve as the sources of the specific transphosphorylating enzymes. F. Leuthardt and H. Nielsen (2) repeated the experiments and demonstrated the conversion of thia mine to DPT in many animal tissues and microorganisms with participation of ATP. K. H. Kiessling (3) observed yeast cells to convert thiamine to mono- and tripho sphothiamine, neither of which alone had cocarboxylase activity However, Rossi Fanelli (4) showed the pure triphosphothiamine isolated from yeast to be able to activate rat-liver pyruvate oxidase system similarly to DPT. N. Shimazono (5) de monstrated more enzymatic formation of DPT by yeast enzyme at certain pH levels when inosine or guanosine-triphosphate was added in place of ATP. He also Liver 4g cold 0.25M sucrose (9 parts) was added found the latter triphosphates to be under stirring replaceable by inosine-monophosphate Homogenate (IMP) plus ATP or guanosine-monophos centrifuged at 600•~g for 10min. Supernatant phate plus ATP. 30ml of 0.04M MgCl2 solution was added No further investigation on the acti and centrifuged at 2200•~g for 5min. Precipitate vation of DPT in pyruvate-oxidase sys 30ml of cold 0.04M MgCl2 solution was added tem seems to have appeared. The au and centrifuged at 2200•~g for 5min. thors attempted to elucidate the existence Precipitate 30ml of cold 0.04M MgCl2 solution was of an additive effect of inosinic acid on added and centrifuged as above. the activation of DPT in liver-pyruvate Precipitate oxidase system. The activity increase cold 0.04M MgCl2 solution was added. of DPT in liver-pyruvate oxidase system Washed liver homogenate, 28mla a The content of nitrogen determined by was confirmed in vitro by addition of micro-Kjeldahl method was found to be IMP or ATP. Further, feeding experi 1 to 2mg/ml. ments were performed with thiamine FIG. 1 Preparation of Washed Liver deficient rats and the response was tested Homogenate 1 Biochemical Studies on Inosinic Acid. III. Partly reported at the Tokyo Meeting of Agricultural Chemical Society, April 22, 1961. 271 272 MAEKAWA, HAYASHI, OSHIMA, SUZUKI AND SAHASHI 1961 with oral administration of IMP. The growth curves did not indicate a positive effect as seen Fig. 1. After 28 day-feeding with thiamine-deficient diet, the animals were killed, and the liver homogenate was tested for the increase of liver-pyruvate oxidase activity after addition of IMP. The marked increase was recognized in the animals receiving thiamine and IMP orally, whereas the activity was low after addi tion of thiamine alone. These findings seem to suggest that IMP may contribute to the activation of DPT in liver-pyruvate oxidase system. Further investigations for the mechanism are now in progress. EXPERIMENTAL 1. Animals (a) The albino rats weighing ca. 100g fed on an ordinary ration were used. (b) Young rats weighing ca. 50g were used. The animals were divided at random into two groups, one of which was fed on a completely thiamine-deficient diet . The other group receiving orally 25ƒÊg of the vitamin per head daily served as a control. The thiamine-deficient diet was composed of, in g, granular sucrose, 56; purified casein, 20; soy bean oil plus cod-liver oil (10:1), 10; and McCollum salt mixture, No. 185, 4. The vitamin mixture, 0.05g, was orally supplemented per head daily . The vitamin mixture (1ml) consisted of, in mg, riboflavin, 0.5; pyridoxine, 0.5; niacin, 2; calcium pantothenate, 2; p-aminobenzoic acid, 10; inositol, 10; choline chloride, 100; folic acid, 2 ; and vitamin B12, 0.01. 2. Preparation of Washed Liver Homogenate The animals were killed, and 4g of the fresh liver was rapidly homogenized after adding 9 parts of cold 0.25M sucrose solution. It was further washed with 0.04M MgCl2 according to Wright (6) as shown Fig. 1. TABLE I Reaction System for Pyruvate Oxidation in Rat Liver Homogenate Vol. 7 ACTIVATION OF DIPHOSPHOTHIAMINE 273 3. Activity Tests for Pyruvate Oxidase in Washed Liver Homogenate Activity test for pyruvate oxidase in the washed liver homogenate was carried out with the modified Wright's pyruvate oxidation system as shown in Table I. The uptake of O2 was estimated using the Warburg apparatus . RESULTS 1. Effect of Thiamine and IMP on the Activation of Pyruvate Oxidase System in Washed Liver Homogenate The rats weighing ca. 100g fed on an ordinary ration were used . First, the additive effect in vitro of thiamine and IMP on the activation of pyruvate oxidase system in the washed liver homogenate was tested . It was found that the uptake of O2 was markedly low when thiamine and IMP were added . (Fig. 2). 2. Additive Effect of IMP on the Activation of Diphosphothiamine in Liver Py ruvate Oxidase System Further experiments were carefully repeated for the confirmation of the addi tive effect of IMP on the activation of liver-pyruvate oxidase system . The results indicated that IMP might contribute to the activation of DPT in liver pyruvate oxidase system, whereas it was rather low when DPT alone was added . (Fig. 3). Comparative test was made to know whether the additive effect of ATP on the activation of pure DPT will be seen in the enzyme system with the results shown in Fig. 3. The test for the additive response of ADP on the same enzyme system showed that the activity was quite lower than after addition of ATP or IMP . (Fig. 4). FIG. 2 Effect of IMP on the Activation Fio. 3 Effect of IMP on the Activation of Liver-Pyruvate Oxidase System of DPT 3. Feeding Experiments of Inosinic Acid in Thiamine-Deficient Rats In the first experiment, the growth curves of thiamine-deficient rats receiving orally inasinic acid were obtained. The single administration of IMP had no growth- 274 MAEKAWA, HAYASHI, OSHIMA, SUZUKI AND SAHASHI 1961 FIG. 4 Effect of ADP on Liver-Pyruvate-Oxidase Activity promoting effect, but administering both thiamine and IMP showed a marked effect. (Fig. 5). In the second experiment, the effect of administering IMP orally on the formation of liver-pyruvate oxidase in thiamine-deficient animals was studied. The pyruvate-oxidase activity in the washed liver homogenate prepared from thiamine-deficient rats receiving IMP was tested. After 28 day-feeding on a thiamine-deficient diet, the animals were killed and the liver was rapidly homo genized as given in Fig. 1. Marked FIG. 5 Growth Curves of Thiamine-De increase of the enzyme activity was re ficient Rats Receiving Thiamine Plus IMP A, thiamine-deficient; B, IMP (1mg) injected; cognized in the rats receiving thiamine C, thiamine (25ƒÊg) orally given; D, thiamine plus IMP, whereas scarcely any response (25ƒÊg) plus IMP (1mg) orally given; E, thia was seen in the animals receiving IMP mine (25ƒÊg) orally given and IMP (1mg) injected. alone by injection (Table II). Vol. 7 ACTIVATION OF DIPHOSPHOTHIAMINE 275 TABLE II Pyruvate Oxidase Activities Expressed as Qo2 (N) in Washed Liver Homogenate of Thiamine-Deficient Rats Receiving Inosinic Acid SUMMARY 1. Additive effect of inosinic acid on the activation of diphosphothiamine in liver pyruvate oxidase system was studied, and the increase in enzyme activity was con firmed by the addition of inosinic acid or adenosine triphosphate in vitro . 2. Further, feeding experiments were carried out with thiamine-deficient rats , and the response was studied after oral administration of inosinic acid . No effect of it on the growth curve was seen, but a marked increase of liver-pyruvate oxidase system was recognized after oral administration of thiamine plus inosinic acid . 3. The results seem to suggest that inosinic acid may contribute to the activation of diphosphothiamine in liver-pyruvate oxidase system. ACKNOWLEDGMENT This work was supported in part by Vitamin B Research Committee and the expense of this research was also partly defrayed by a grant in aid from the Central Research Laboratory of Ajinomoto Co., Inc., to which the authors express their thanks . REFERENCES 1. Lohmann, K., and Schuster, P., Biochem . Z. 294, 188 (1937). 2. Leuhardt, F., and Nielsen, H., Helv. Chim. Acta 35, 1196 (1952). 3. Kiessling, K.H., Biochem. et Biophys . Acta 20, 293 (1956). 4. Rossi-Fanelli, Proc. International Symp. Enzyme Chem . (Tokyo & Kyoto) 119 (1957). 5. Shimazono, N., J. Biochem. 46, 963 (1959). 6. Wright, R. C., and Scott, E. M., J. Biol. Chem. 206, 725 (1954)..
Recommended publications
  • P2X7 Receptor Suppression Preserves Blood-Brain Barrier
    www.nature.com/scientificreports OPEN P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation Received: 15 November 2015 Accepted: 03 March 2016 after Experimental Intracerebral Published: 16 March 2016 Hemorrhage in Rats Hengli Zhao1, Xuan Zhang1, Zhiqiang Dai1, Yang Feng1, Qiang Li1, John H. Zhang2, Xin Liu1, Yujie Chen1 & Hua Feng1 Blockading P2X7 receptor(P2X7R) provides neuroprotection toward various neurological disorders, including stroke, traumatic brain injury, and subarachnoid hemorrhage. However, whether and how P2X7 receptor suppression protects blood-brain barrier(BBB) after intracerebral hemorrhage(ICH) remains unexplored. In present study, intrastriatal autologous-blood injection was used to mimic ICH in rats. Selective P2X7R inhibitor A438079, P2X7R agonist BzATP, and P2X7R siRNA were administrated to evaluate the effects of P2X7R suppression. Selective RhoA inhibitor C3 transferase was administered to clarify the involvement of RhoA. Post-assessments, including neurological deficits, Fluoro-Jade C staining, brain edema, Evans blue extravasation and fluorescence, western blot, RhoA activity assay and immunohistochemistry were performed. Then the key results were verified in collagenase induced ICH model. We found that endogenous P2X7R increased at 3 hrs after ICH with peak at 24 hrs, then returned to normal at 72 hrs after ICH. Enhanced immunoreactivity was observed on the neurovascular structure around hematoma at 24 hrs after ICH, along with perivascular astrocytes and endothelial cells. Both A438079 and P2X7R siRNA alleviated neurological deficits, brain edema, and BBB disruption after ICH, in association with RhoA activation and down-regulated endothelial junction proteins. However, BzATP abolished those effects. In addition, C3 transferase reduced brain injury and increased endothelial junction proteins’ expression after ICH.
    [Show full text]
  • Biochemical Differences Among Four Inosinate Dehydrogenase Inhibitors
    [CANCER RESEARCH 45.5512-5520, November 1985] Biochemical Differences among Four Inosinate Dehydrogenase Inhibitors, Mycophenolic Acid, Ribavirin, Tiazofurin, and Selenazofurin, Studied in Mouse Lymphoma Cell Culture1 Huey-Jane Lee, Katarzyna Pawlak, Binh T. Nguyen, Roland K. Robins, and Wolfgang Sadee2 Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco, California 94143 [H-J. L, K. P., B. T. N., W. S.], and Cancer Research Center, Department of Chemistry, Brigham Young University, Provo, Utah 84602 [R. K. R.J ABSTRACT 1.2.1.14) catalyzes the conversion of IMP to xanthylate, and it represents a key enzyme in the biosynthesis of guanine nucleo- The mechanism of the cellular toxicity of four ¡nosinatedehy- tides. The activity of IMP dehydrogenase is positively linked to drogenase (IMP-DH) inhibitors with different antitumor and anti cellular transformation and tumor progression; therefore, this viral pharmacological profiles was investigated in mouse lym- enzyme represents a promising target of cancer chemotherapy phoma (S-49) cell culture. Drug effects on cell growth, nucleotide (1-3). Inhibition of IMP dehydrogenase results in the depletion pools, and ÒNA and RNA synthesis were measured in the of cellular guanine nucleotides by blocking their de novo synthe presence and absence of guanine salvage supplies. Both guanine and guanosine were capable of bypassing the IMP-DH block, sis (4). Guanine nucleotides are required as substrates, activa while they also demonstrated some growth-inhibitory
    [Show full text]
  • 2'-Deoxyguanosine Toxicity for B and Mature T Lymphoid Cell Lines Is Mediated by Guanine Ribonucleotide Accumulation
    2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. Y Sidi, B S Mitchell J Clin Invest. 1984;74(5):1640-1648. https://doi.org/10.1172/JCI111580. Research Article Inherited deficiency of the enzyme purine nucleoside phosphorylase (PNP) results in selective and severe T lymphocyte depletion which is mediated by its substrate, 2'-deoxyguanosine. This observation provides a rationale for the use of PNP inhibitors as selective T cell immunosuppressive agents. We have studied the relative effects of the PNP inhibitor 8- aminoguanosine on the metabolism and growth of lymphoid cell lines of T and B cell origin. We have found that 2'- deoxyguanosine toxicity for T lymphoblasts is markedly potentiated by 8-aminoguanosine and is mediated by the accumulation of deoxyguanosine triphosphate. In contrast, the growth of T4+ mature T cell lines and B lymphoblast cell lines is inhibited by somewhat higher concentrations of 2'-deoxyguanosine (ID50 20 and 18 microM, respectively) in the presence of 8-aminoguanosine without an increase in deoxyguanosine triphosphate levels. Cytotoxicity correlates instead with a three- to fivefold increase in guanosine triphosphate (GTP) levels after 24 h. Accumulation of GTP and growth inhibition also result from exposure to guanosine, but not to guanine at equimolar concentrations. B lymphoblasts which are deficient in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase are completely resistant to 2'-deoxyguanosine or guanosine concentrations up to 800 microM and do not demonstrate an increase in GTP levels. Growth inhibition and GTP accumulation are prevented by hypoxanthine or adenine, but not by 2'-deoxycytidine.
    [Show full text]
  • Synthesis and Biological Evaluation of Purine and Pyrimidine Based Ligands for the A3 and the P2Y2 Purinergic Receptors
    Synthesis and Biological Evaluation of Purine and Pyrimidine Based Ligands for the A3 and the P2Y2 Purinergic Receptors Apr. Liesbet Cosyn Thesis submitted to the Faculty of Pharmaceutical Sciences to obtain the degree of Doctor in Pharmaceutical Sciences Promoter Prof. dr. apr. Serge Van Calenbergh Academic year 2007-2008 TABLE OF CONTENTS 1 INTRODUCTION ................................................................................................. 3 1.1 Purinergic Receptors ................................................................................. 3 1.2 Adenosine Analogues and the Adenosine A3 Receptor ......................... 4 1.2.1 Adenosine................................................................................................. 4 1.2.2 The Adenosine Receptors: G-protein-Coupled Receptors........................ 7 1.2.3 Adenosine Receptor Subtypes and Their Signalling............................... 10 1.2.4 The Adenosine A3 Receptor ................................................................... 12 1.2.4.1 Adenosine A3 Receptor Agonists ................................................. 12 1.2.4.2 Adenosine A3 Receptor Antagonists ............................................ 16 1.2.4.3 Allosteric Modulation.................................................................... 21 1.2.4.4 Molecular Modeling of the Adenosine A3 Receptor...................... 22 1.2.4.5 The Neoceptor concept................................................................ 23 1.2.4.6 Therapeutic Potential of A3AR Agonists......................................
    [Show full text]
  • Reversibility Ofthe Pyrophosphoryl Transfer from ATP to GTP By
    Proc. Nat. Acad. Sci. USA Vol. 71, No. 9, pp. 3470-3473, September 1974 Reversibility of the Pyrophosphoryl Transfer from ATP to GTP by Escherichia coli Stringent Factor (guanosine 5'-diphosphate-3'-diphosphate/guanosine 5'-triphosphate-3'-diphosphate/relaxed control/ribosomes) JOSE SY The Rockefeller University, New York, N.Y. 10021 Communicated by Fritz Lipmann, July 1, 1974 ABSTRACT The stringent factor-catalyzed, ribosome- was incubated for 60 min at 300 in a 1W0-1 mixture contain- dependent synthesis of guanosine polyplosphates is ing: 50 mM Tris OAc, pH 8.1; 4 mM dithiothreitol; 20 mM found to be reversible. The reverse reaction specifically requires 5'-AMP as the pyrophosphoryl acceptor, and Mg(OAc)2; 5 mM ATP; 10 ,ug of poly(A, U, G); 27 pgof tRNA; guanosine 5'-triphosphate-3'-diphospbate is preferentially 90',g of ethanol-washed ribosomes; and 2 p&g of fraction II utilized as the pyrophosphoryl donor. The primary prod- stringent factor. By minimizing GTPase activity with the ucts of the reaction are GTP and ANP. The reverse reaction use of high Mg++ concentration and ethanol-washed ribo- is strongly inhibited by the antibiotics thiostrepton and a ob- tetracycline, and b' A P and,1-y-pnethylene-adenosixie- somes with a minimal time of incubation, product is triphosphate, but not by ADP, GTP, and GIDP. The reverse tained that is more than 95% pppGpp. After incubation, 1 Al reaction occurs under conditions for nonribosomal syn- of 88% HCOOH was added and the resulting precipitate dis- thesis. The ove'rill reaction for stringent factor-catalyzed carded.
    [Show full text]
  • Mechanisms of Synthesis of Purine Nucleotides in Heart Muscle Extracts
    Mechanisms of Synthesis of Purine Nucleotides in Heart Muscle Extracts David A. Goldthwait J Clin Invest. 1957;36(11):1572-1578. https://doi.org/10.1172/JCI103555. Research Article Find the latest version: https://jci.me/103555/pdf MECHANISMS OF SYNTHESIS OF PURINE NUCLEOTIDES IN HEART MUSCLE EXTRACTS1 BY DAVID A. GOLDTHWAIT2 (From the Departments of Biochemistry and Medicine, Western Reserve University, Cleveland, Ohio) (Submitted for publication February 18, 1957; accepted July 18, 1957) The key role of ATP, a purine nucleotide, in 4. Adenine or Hypoxanthine + PRPP -> AMP the conversion of chemical energy into mechanical or Inosinic Acid (IMP) + P-P. work by myocardial tissue is well established (1, The third mechanism of synthesis is through the 2). The requirement for purine nucleotides has phosphorylation of a purine nucleoside (8, 9): also been demonstrated in the multiple synthetic 5. Adenosine + ATP -, AMP + ADP. reactions which maintain all animal cells in the Several enzymatic mechanisms are known which steady state. Since the question immediately arises result in the degradation of purine nucleotides and whether the purine nucleotides are themselves in nucleosides. The deamination of adenylic acid is a steady state, in which their rates of synthesis well known (10): equal their rates of degradation, it seems reason- 6. AMP -* IMP + NH8. able to investigate first what mechanisms of syn- Non-specific phosphatases (11) as well as spe- thesis and degradation may be operative. cific 5'-nucleotidases (12) have been described At present, there are three known pathways for which result in dephosphorylation: the synthesis of purine nucleotides. The first is 7.
    [Show full text]
  • Calcium 5'-Ribonucleotides
    CALCIUM 5'-RIBONUCLEOTIDES Prepared at the 18th JECFA (1974), published in NMRS 54B (1975) and in FNP 52 (1992). Metals and arsenic specifications revised at the 57th JECFA (2001). An ADI ‘not specified’ was established at the 18th JECFA (1974). SYNONYMS Calcium ribonucleotides, INS No. 634 DEFINITION Chemical names (Mixture of) calcium inosine-5'-monophosphate and calcium guanosine-5'- monophosphate Chemical formula C10H11CaN4O8P · x H2O and C10H12CaN5O8P · x H2O Structural formula Calcium 5’-guanylate Calcium 5’-inosinate Assay Not less than 97% and not more than the equivalent of 102% of C10H11CaN4O8P and C10H12CaN5O8P, calculated on the anhydrous basis. The proportion of C10H11CaN4O8P or C10H12CaN5O8P to the sum of them is between 47% and 53%. DESCRIPTION Odourless, white or off-white crystals or powder FUNCTIONAL USES Flavour enhancer CHARACTERISTICS IDENTIFICATION Solubility (Vol. 4) Sparingly soluble in water Test for ribose (Vol. 4) Passes test Test for organic phosphate Passes test (Vol. 4) Test 5 ml of a 1 in 2,000 solution Test for inosinic acid To 2 ml of a 1 in 2,000 solution add 2 ml of 10% hydrochloric acid and 0.1 g of zinc powder, heat in a water bath for 10 min, and filter. Cool the filtrate in ice water, add 1 ml of a 3 in 1,000 sodium nitrite solution, shake well, and allow to stand for 10 min. Add 1 ml of a 1 in 200 ammonium sulfamate solution, shake well, and allow to stand for 5 min. Add 1 ml of a 1 in 500 N-(1- naphthyl)-ethylenediamine dihydrochloride solution.
    [Show full text]
  • Central Nervous System Dysfunction and Erythrocyte Guanosine Triphosphate Depletion in Purine Nucleoside Phosphorylase Deficiency
    Arch Dis Child: first published as 10.1136/adc.62.4.385 on 1 April 1987. Downloaded from Archives of Disease in Childhood, 1987, 62, 385-391 Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency H A SIMMONDS, L D FAIRBANKS, G S MORRIS, G MORGAN, A R WATSON, P TIMMS, AND B SINGH Purine Laboratory, Guy's Hospital, London, Department of Immunology, Institute of Child Health, London, Department of Paediatrics, City Hospital, Nottingham, Department of Paediatrics and Chemical Pathology, National Guard King Khalid Hospital, Jeddah, Saudi Arabia SUMMARY Developmental retardation was a prominent clinical feature in six infants from three kindreds deficient in the enzyme purine nucleoside phosphorylase (PNP) and was present before development of T cell immunodeficiency. Guanosine triphosphate (GTP) depletion was noted in the erythrocytes of all surviving homozygotes and was of equivalent magnitude to that found in the Lesch-Nyhan syndrome (complete hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency). The similarity between the neurological complications in both disorders that the two major clinical consequences of complete PNP deficiency have differing indicates copyright. aetiologies: (1) neurological effects resulting from deficiency of the PNP enzyme products, which are the substrates for HGPRT, leading to functional deficiency of this enzyme. (2) immunodeficiency caused by accumulation of the PNP enzyme substrates, one of which, deoxyguanosine, is toxic to T cells. These studies show the need to consider PNP deficiency (suggested by the finding of hypouricaemia) in patients with neurological dysfunction, as well as in T cell immunodeficiency. http://adc.bmj.com/ They suggest an important role for GTP in normal central nervous system function.
    [Show full text]
  • Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells
    Effects of allopurinol and oxipurinol on purine synthesis in cultured human cells William N. Kelley, James B. Wyngaarden J Clin Invest. 1970;49(3):602-609. https://doi.org/10.1172/JCI106271. Research Article In the present study we have examined the effects of allopurinol and oxipurinol on thed e novo synthesis of purines in cultured human fibroblasts. Allopurinol inhibits de novo purine synthesis in the absence of xanthine oxidase. Inhibition at lower concentrations of the drug requires the presence of hypoxanthine-guanine phosphoribosyltransferase as it does in vivo. Although this suggests that the inhibitory effect of allopurinol at least at the lower concentrations tested is a consequence of its conversion to the ribonucleotide form in human cells, the nucleotide derivative could not be demonstrated. Several possible indirect consequences of such a conversion were also sought. There was no evidence that allopurinol was further utilized in the synthesis of nucleic acids in these cultured human cells and no effect of either allopurinol or oxipurinol on the long-term survival of human cells in vitro could be demonstrated. At higher concentrations, both allopurinol and oxipurinol inhibit the early steps ofd e novo purine synthesis in the absence of either xanthine oxidase or hypoxanthine-guanine phosphoribosyltransferase. This indicates that at higher drug concentrations, inhibition is occurring by some mechanism other than those previously postulated. Find the latest version: https://jci.me/106271/pdf Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells WILLIAM N. KELLEY and JAMES B. WYNGAARDEN From the Division of Metabolic and Genetic Diseases, Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27706 A B S TR A C T In the present study we have examined the de novo synthesis of purines in many patients.
    [Show full text]
  • GUANOSINE TRIPHOSPHATE* Protein Synthesis Accompanying the Regeneration of Rat Liver Offered a Dramatic One Could Reproduce in V
    1184 BIOCHEMISTRY: HOAGLAND ET AL. PROC. N. A. S. and Structure of Macromolecules, Cold Spring Harbor Symposia on Quantitative Biology, vol. 28 (1963), p. 549. 3 Speyer, J., P. Lengyel, C. Basilio, A. J. Wahba, R. S. Gardner, and S. Ochoa, in Synthesis and Structure of Macromolecules, Cold Spring Harbor Symposia on Quantitative Biology, vol. 28 (1963), p. 559. 4 Doctor, B. P., J. Apgar, and R. W. Holley, J. Biol. Chem., 236, 1117 (1961). 6 Weisblum, B., S. Benzer, and R. W. Holley, these PROCEEDINGS, 48, 1449 (1962). 6 von Ehrenstein, G., and D. Dais, these PROCEEDINGS, 50, 81 (1963). 7 Sueoka, N., and T. Yamane, these PROCEEDINGS, 48, 1454 (1962). 8 Yamane, T., T. Y. Cheng, and N. Sueoka, in Synthesis and Structure of Macromolecules, Cold Spring Harbor Symposia on Quantitative Biology, vol. 28 (1963), p. 569. 9 Benzer, S., personal communication. 10 Bennett, T. P., in Synthesis and Structure of Macromolecules, Cold Spring Harbor Symposia on Quantitative Biology, vol. 28 (1963), p. 577. 11 Yamane, T., and N. Sueoka, these PROCEEDINGS, 50, 1093 (1963). 12 Berg, P., F. H. Bergmann, E. J. Ofengand, and M. Dieckmann, J. Biol. Chem., 236, 1726 (1961). 13Bennett, T. P., J. Goldstein, and F. Lipmann, these PROCEEDINGS, 49, 850 (1963). 14 Keller, E. B., and R. S. Anthony, Federation Proc., 22, 231 (1963). ASPECTS OF CONTROL OF PROTEIN SYNTHESIS IN NORMAL AND REGENERATING RA T LIVER, I. A MICROSOMAL INHIBITOR OF AMINO ACID INCORPORATION WHOSE ACTION IS ANTAGONIZED BY GUANOSINE TRIPHOSPHATE* BY MAHLON B. HOAGLAND, OSCAR A. SCORNIK, AND LORRAINE C. PFEFFERKORN DEPARTMENT OF BACTERIOLOGY AND IMMUNOLOGY, HARVARD MEDICAL SCHOOL, BOSTON Communicated by John T.
    [Show full text]
  • Consequences of Methotrexate Inhibition of Purine Biosynthesis in L5178Y Cells'
    [CANCER RESEARCH 35, 1427-1432,June 1975] Consequences of Methotrexate Inhibition of Purine Biosynthesis in L5178Y Cells' William M. Hryniuk2 Larry W. Brox,3J. Frank Henderson, and Taiki Tamaoki DepartmentofMedicine, University ofManitoba,and TheManitoba Institute ofCellBiology, Winnipeg,Manitoba [W. M. H.J and CancerResearch Unit (McEachern Laboratory), and DepartmentofBiochemistry, University ofAlberta, Edmonton,Alberta T6G 2E1 [L. W. B.,J. F. H., T. T.J,Canada SUMMARY recently been shown that the cytotoxicity of methotrexate against cultured mouse lymphoma L5178Y cells is in part Addition of 1 @Mmethotrexate to cultures of L5178Y attributable to a “purineless―state(6, 7). Thus, hypoxan cells results in an initial inhibition ofthymidine, uridine, and thine partially prevented the methotrexate-induced inhibi leucine incorporation into acid-insoluble material followed, tion of thymidine, uridine, and leucine incorporation into after about 10 hr. by a partial recovery in the extent of macromolecules and also delayed the loss ofcell viability, as incorporation of these precursors. Acid-soluble adenosine measured by cloning experiments. These studies also triphosphate and guanosine triphosphate concentrations are showed that, during incubation of L5178Y cells with greatly reduced initially, but guanosine triphosphate con methotrexate in the absence of hypoxanthine, incorporation centrations appear to recover partially by 10 hr. Acid of thymidine into DNA was first inhibited but later partially soluble uridine triphosphate and cytidine
    [Show full text]
  • Alternative Pathways of Glucose Metabolism II. Nucleotides from The
    Alternative Pathways of Glucose Metabolism II . Nucleotides from the Acid-soluble Fraction of Normal and Tumor Tissues and Studies on Nucleic Acid Synthesis in Tumors*t HANNS SCHMITZ4 VAN R. POTTER, ROBERT B. HTJRLBERT,@ AND DWAIN M. WHITE (McArdie Memovial Laboratory, the Medical School, University of Wisconain, Madison, WI..) The first paper (18) in this series on the alterna MATERIALS AND METHODS tive pathways of glucose metabolism established The present study has involved the measure the fact that radioactivity from glucose-i-C'4 was ment of the specific activities of the free 5' mono-, readily incorporated into the pentose moiety of the di-, and triphosphates of adenosine, guanosine, ribonucleic and desoxyribonucleic acids of Flexner cytidine, and uridine from the acid-soluble extract Jobling tumors in rats, and described the over-all of tumor tissue in relation to the specific activities distribution of radioactivity in the acid-soluble of the corresponding nucleotides that were oh and acid-insoluble fractions of tumor and liver tis tamed by chemical or enzymatic hydrolysis of the sue at various time periods. The acid-soluble frac nucleic acids from the same tissue samples, at tion of tissue contains an appreciable amount of specified time intervals after the injection of glu free nucleotides which are possible intermediary cose-1-C'4. The experimental plan corresponds compounds in the synthesis of the nucleic acids exactly to that described in the preceding paper; (6, 7, 8, 9, 13, 16). It was noted (18) that as the C'4 many of
    [Show full text]